Searchable abstracts of presentations at key conferences in endocrinology

ea0061p005 | (1) | OU2019

Metabolic health and different body composition phenotypes in a Maltese cohort

Agius Rachel , Pace Nikolai , Fava Stephen

It is known that a subset of obese individuals do not exhibit features of the metabolic syndrome (Met-S); these are referred to as being metabolically healthy obese (MHO) individuals. Conversely there are other individuals who although have a normal BMI are insulin resistant and exhibit some of the features of the Met-S and are termed as being metabolically unhealthy normal weight (MUHNW) individuals. This study aims to identify the prevalence of metabolic health among a diffe...

ea0070aep171 | Bone and Calcium | ECE2020

Does real-life time spent within the therapeutic range affect degree of improvement in bone mineral density in men receiving testosterone therapy for hypogonadism?

Osei-Osafo Stephen , Sharma Dushyant , Beeharry Deepa

Background: Hypogonadism in males is associated with a reduction in bone mineral density (BMD). It is known that the reversal of this is achievable through adequate hormone replacement; however, the degree to which this is dependent on the proportion of time patients spend within the recommended therapeutic range (>15 nmol/l) in real-ife has not yet been established.Aim: To evaluate the degree to which the proportion of time that a hypogonadal p...

ea0027p72 | (1) | BSPED2011

Which test to use for screening glucose intolerance in overweight/obese children?

O'Riordan Stephen , Greening James , Shenoy Savitha

Background: With the increasing prevalence of obesity and related morbidity including glucose intolerance in childhood, there remains a dispute about the best screening test to identify this early. The aim of our study was to determine the prevalence of impaired glucose tolerance (IGT)/type 2 diabetes mellitus (T2DM) in a multiethnic cohort of 100 overweight/obese children and adolescents in our clinic and compare the results of the screening tests.Study...

ea0025p277 | Reproduction | SFEBES2011

Increased intensity of P450c17 protein expression in theca cells from polycystic ovaries

Comim Fabio , Hardy Kate , Franks Stephen

Background/aims: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women, being characterized by ovarian hyperandrogenism attributed to intrinsic overproduction by theca cells (TCs). Although previous reports pointed a higher stability and transcription of CYP17mRNA (Wickenheisser JK et al. 2006)1, few have examined (and none has quantified) P450c17 protein expression in TCs from PCOS ovaries. Therefore, the aim of this study is to qua...

ea0018p35 | (1) | MES2008

An unusual case of primary infertility

Amin Anjali , Robinson Stephen , Webber Lisa

We present a case of a 29-year-old lady who presented with subfertility. She had had a 2 years history of oligomenorrhoea with highly irregular menses. She had symptoms of depression and described tunnel vision. Clinically, she was euendocrine with no features of hormonal excess or deficiency. She was not hirsute. Visual field testing demonstrated a severe left superior temporal quadrantopia.Laboratory investigations demonstrated an oestriadol level rang...

ea0015p61 | Clinical practice/governance and case reports | SFEBES2008

Like mother like son: a case of maternal and neonatal water intoxication

Simmgen Marcus , Nussey Stephen , Bano Gul

A 37-year old woman developed grand-mal seizures shortly after having given vaginal birth at term. Three hours later, her newborn son also had a tonic-clonic seizure. Following the convulsions, maternal fractures of the humerus and the neck of femur were detected.The pregnancy had been uneventful except for hip pains for 4 weeks prior to delivery. For years, the patient had been ingesting 5 l of bottled water daily. Labour had set in spontaneously and sh...

ea0015p218 | Pituitary | SFEBES2008

Long term, high dose oestrogen treatment has no effect on prolactin levels and normalises gonadotrophin levels

Sathyapalan Thozhukat , Gonz'alez Susana , Atkin Stephen L

Context: Exogenous oestrogen administration causes prolactinoma formation in rats and there are anecdotal reports of oestrogen treatment and prolactinoma formation in gender reassignment males to females. It remains unclear whether chronic exposure to high dose oestrogen in women is linked with prolactinoma development.Aim: The aim of this study was to determine the effect of high dose subcutaneous estrogen on prolactin and gonadotrophin levels of 101 wo...

ea0015p219 | Pituitary | SFEBES2008

Low dose cabergoline in hyperprolactinaemia is not associated with clinically significant valvular heart disease

Wakil Ammar , Clark Andrew , Atkin Stephen

Introduction: Recent trials suggest that using ergot-derived dopamine agonists such as cabergoline in the treatment of Parkinson’s disease is associated with an increased risk of valvular heart disease. However, the dose of cabergoline used to treat hyperprolactinaemia is considerably less than that used in Parkinson’s disease.Study design: A cross-sectional study; forty four patients, who received cabergoline for at least 6 months, underwent t...

ea0015p244 | Pituitary | SFEBES2008

Discordant stimulated growth hormone (GH) responses in cranially irradiated adult cancer survivors may occur in the presence of normal GH status: compensated GH deficiency

Darzy Ken , Thorner Michael , Shalet Stephen

Context: We have previously demonstrated that, in cranially irradiated patients with normal peak GH responses to both the insulin tolerance test (ITT) and the growth hormone-releasing hormone plus arginine stimulation test (GHRH+AST), somatotroph reserve can be substantially reduced, while individual and overall spontaneous GH secretion remain entirely normal due presumably to a compensatory increase in hypothalamic stimulatory input within a partially damaged hypothalamic pit...

ea0015p284 | Reproduction | SFEBES2008

Changes in lipid profile and hs-CRP in polycystic ovarian syndrome after treatment with metformin, orlistat and pioglitazone

Cho Li-Wei , Kilpatrick Eric , Atkin Stephen

Background: Polycystic ovary syndrome (PCOS) is common with a suggested prevalence of 6–7% in Caucasian women of reproductive age. The presence of cardiovascular risk factors of obesity, insulin resistance and dyslipidaemia may predispose women with PCOS to coronary heart disease, although this remains controversial. This study aimed to contrast and compare the changes in lipid profile and hs-CRP following treatment with metformin, orlistat and pioglitazone in women with ...